February 01, 2026 — RNews

#insulin resistance — Sunday, February 01, 2026 (1 items)

hot top new

← prev day next day →

0

Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial. (nature.com)

Malhotra A … Bednarik J Nature Medicine 2026-02-01

#inflammation #cardiometabolic #obesity #insulin resistance #sleep apnea